2021 presentations - Practical Recommendations in Immuno and Molecular Oncology (PRIMO)

2021 Presentations

Hematologic Malignancies - Julie Vose / Sagar Lonial
Indolent and Aggressive NHL Including CAR-T
Smoldering MM and Early Therapy vs Observation
AML/MDS: Update on Therapy

Hematologic Malignancies (cont.)
CLL: What is the Best Initial Therapy for a Newly Diagnosed patient?
Update on ALL Therapy

Gastrointestinal Malignancies – Rachna T. Shroff
Colon Cancer - Divide and Conquer
Hot Topics in Pancreatic and Biliary Cancer
Five Years In; How Far Reaching Have Biosimilars Been in the US?

Melanoma, Skin Cancers, RCC – Shane Morita
Melanoma: Keeping Up With the Data
Sarcoma: Where are We Making Progress?
Medical Therapy for Head and Neck Cancers: Current Status

GU Cancers - Donald Trump
Bladder Cancer: Sequencing Therapeutic Choices
RCC: A Surfeit of Riches – What’s a Clinician to Do?
Impact of COVID-19 on Cancer Care

Immunotherapy for Advanced NSCLC.
Matching Drugs to Targets in NSCLC
Therapeutic Advances in SCLC;

Breast Cancer - Hope S. Rugo, MD
New Directions in the Treatment of ER+ Breast Cancer
Updates in the Treatment of HER2+ Breast Cancer
Triple Negative Breast Cancer: Immunotherapy and Novel Agents
Breast Cancer - Hope S. Rugo, MD
Managing the Toxicity of Endocrine Therapy: Diet, Exercise, Sexual Health
Genomics to Guide Therapy in Early and Late Stage Breast Cancer
Metastatic Survivorship Care
SITC on Practical Recommendations Including Reimbursement Issues
Other Women's Cancers - Hope S. Rugo, MD
Ovarian Cancer: PARP, Bevacizumab, Immunotherapy
Cervical and Uterine Cancer Updates